Switching ART Regimens Didn't Lead to Weight Loss in Patients With HIV and Obesity

(MedPage Today) — Adults with HIV and obesity who switched from an antiretroviral therapy (ART) regimen with an integrase strand transfer inhibitor (INSTI) and tenofovir alafenamide to doravirine with or without tenofovir disoproxil fumarate did…

Source link : https://www.medpagetoday.com/meetingcoverage/ias/116549

Author :

Publish date : 2025-07-17 17:14:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Switching ART Regimens Didn’t Lead to Weight Loss in Patients With HIV and Obesity

Familiar Anti-Inflammatory Felled by Strokes in TAVR Trial

Are MAHA ‘Wins’ Really Net Losses? Labubu to ‘La-poopoo’; Docs Clap Back at Insurers

Related Posts

FDA Reviewers Flag Inconsistent Data for Rexulti in PTSD

Myeloma Drug’s Comeback Nixed by FDA Panel

A ‘Culture Change’ Is Needed in Academic Medicine, FDA Commissioner Says

Doctors Who Use AI Perceived Less Favorably, Survey Suggests

Duchenne Gene Therapy Will Undergo Changes After Patient Deaths

Farm Women With Rheumatoid Arthritis: Are Pesticides to Blame?